SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Gabe Fernandez who wrote (1174)8/25/1998 9:39:00 AM
From: Ron  Read Replies (1) | Respond to of 1491
 
Ariella, yosi Zvi et all-----greetings! I just returned from a summer vacation and see Pars way down. I have read a few prior post, but just want to be assured, if possible, that what is happeneing to our stock is just "time"----meaning the day to day traders got out because unblinding did not happen yet for HU-211. Is there a scheduled time for release of such info? Also has a marketing partner for Alrex been named?........AND GET THIS---my broker called little ole me asking about PARS saying a few people are starting to inquire from him. And thanks to all of you I was able to give a lot of info....Thanks in advance for reply .....RON



To: Gabe Fernandez who wrote (1174)8/25/1998 1:43:00 PM
From: Ariella  Respond to of 1491
 
Dear Gabe, I've just had a long call with a PARS follower in Israel.
We talked about the recent speculation that waves of selling were coming from Israel based on volumes done through Oppenheimer (that brokerage company does about 50% of all Israel trades on US stocks).

My source tells me, however, that the speculation is wrong. Oppenheimer is the largest MM for PARS, so large selling might have come through it BUT he's been told that Israeli's were net buyers of PARS recently.

All in all, I'm feeling ok about my investment despite the price decline. Too many reports that PARS scientists are feeling quite upbeat; the choice of the Waldorf to "celebrate," the probable hiring of outside PR at a time when it would be prudent to save money unless we were expecting HU-211 to go forward, the spring insider purchases. What's coming from the company sounds good; what's coming from investors who are reading tea leaves through the stock price sounds bad. Our nervousness is understandable, but I think those of us that stick it out will be rewarded.

As for your question about about the second conference at which a paper on HU-211 is supposed to be delivered. On the August conference call Bob Cook said it would be in LA in November.
Sorry, don't recall the name of the group. Does anyone else?

Regards,
Ariella